Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal Cancer
2014 · Annals of Surgery · 233 citations
https://doi.org/10.1097/sla.0000000000000614
J
Joanne F. Chou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
456
Papers
8.4K
Citations
40
h-index
93
i10-index
Joanne F. Chou is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Esophageal Cancer Research and Treatment & Lung Cancer Treatments and Mutations. The author has an h-index of 40, co-authored 388 publications.
ORCID: 0000-0002-6866-2022Papers by this author
worksClinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival
2025 · Nature Medicine · 60 citations
https://doi.org/10.1038/s41591-024-03362-3
Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis
2016 · Leukemia · 55 citations
https://doi.org/10.1038/leu.2016.229
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer
2023 · Clinical Cancer Research · 25 citations
https://doi.org/10.1158/1078-0432.ccr-22-3769
The Evolutionary Forest of Pancreatic Cancer
2024 · Cancer Discovery · 20 citations
https://doi.org/10.1158/2159-8290.cd-23-1541
Noninvasive Assessment of Human Epidermal Growth Factor Receptor 2 (HER2) in Esophagogastric Cancer Using<sup>89</sup>Zr-Trastuzumab PET: A Pilot Study
2022 · Journal of Nuclear Medicine · 19 citations
https://doi.org/10.2967/jnumed.122.264470
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat